Plasma YKL-40 as a biomarker for poor prognosis in patients with metastatic colorectal cancer treated with 3. line cetuximab and irinotecan

B. V. Jensen, K-L G Spindler, I. J. Christensen, JV Schou, D. L. Nielsen, A Jakobsen, E. Hogdall, P Pfeiffer, M. K. Yilmaz, J Johansen

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
Artikelnummer95P
TidsskriftAnnals of Oncology
Vol/bind27
Udgave nummerSuppl. 6
ISSN0923-7534
DOI
StatusUdgivet - 2016
Begivenhed41st ESMO Congress: From disease treatment to patient care - København, Danmark
Varighed: 7 okt. 201611 okt. 2016
Konferencens nummer: 41
http://www.esmo.org/Conferences/Past-Conferences/ESMO-2016-Congress

Konference

Konference41st ESMO Congress
Nummer41
LandDanmark
ByKøbenhavn
Periode07/10/201611/10/2016
Internetadresse

Citationsformater